Gds Wealth Management Astrazeneca PLC Transaction History
Gds Wealth Management
- $1.16 Billion
- Q1 2025
A detailed history of Gds Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Gds Wealth Management holds 5,147 shares of AZN stock, worth $362,245. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,147
Previous 4,973
3.5%
Holding current value
$362,245
Previous $325,000
16.31%
% of portfolio
0.03%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.02 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.86 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.24 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.2 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $218B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...